Article Details
Retrieved on: 2022-12-11 13:58:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs analysts adjusted the rating due to concerns over the clinical, regulatory, financing, competitive, and commercial path for the ...
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here